In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study

Published:2024-11 Issue: Volume:62 Page:102780
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Cedrone Edward,Ishaq Abbas,Grabarnik Emma,Edmondson Elijah,Skoczen Sarah,Neun Barry W.,Freer Matthew,Shuttleworth Siannah,Sviland Lisbet,Dickinson Anne,Dobrovolskaia Marina A.

Funder

National Institutes of Health

National Cancer Institute

DHHS

Publisher

Elsevier BV

Reference44 articles.

1. The hand-foot syndrome—a frequent secondary manifestation in antineoplastic chemotherapy;Janusch;Eur J Dermatol,2006

2. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre;Webster-Gandy;Eur J Oncol Nurs,2007

3. Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts;von Moos;Eur J Cancer,2008

4. Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects;Zhu;Eur J Hosp Pharm,2020

5. Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer;Tanyi;Gynecol Oncol,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP